United States · FDA National Drug Code directory
TONMYA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70792-102_c3457853-101e-46ee-899a-1f7539017eab
- Product NDC
- 70792-102
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Cyclobenzaprine Hydrochloride
- Labeler
- Tonix Medicines, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250815
- Source listing expiry
- 20271231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 2.8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (70792-102-14) · 70792-102-14
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (70792-102-30) · 70792-102-30
- 60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (70792-102-60) · 70792-102-60
- 90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (70792-102-90) · 70792-102-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →